HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthieu Million Selected Research

Hydroxychloroquine (Plaquenil)

1/2022Re: Treatment of Coxiella burnetii endocarditis with hydroxychloroquine by Stahl et al.
1/2022Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis.
12/2021SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment.
1/2021Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
1/2021Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
1/2021Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study.
1/2021Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
1/2021Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin.
1/2021Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
7/2020Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthieu Million Research Topics

Disease

17COVID-19
01/2022 - 01/2020
16Infections
01/2022 - 01/2009
15Q Fever (Fever, Q)
01/2020 - 08/2010
14Endocarditis
01/2022 - 08/2010
4Severe Acute Malnutrition
01/2020 - 01/2016
3Lymphopenia (Lymphocytopenia)
12/2021 - 07/2020
3Weight Gain
10/2021 - 02/2013
3Thrombosis (Thrombus)
05/2019 - 07/2017
3Clostridium Infections
10/2018 - 08/2015
2Malaria
10/2021 - 08/2021
2Dysbiosis
08/2021 - 10/2015
2Communicable Diseases (Infectious Diseases)
08/2021 - 03/2020
2Kwashiorkor
01/2021 - 01/2019
2Thrombocytopenia (Thrombopenia)
12/2020 - 07/2017
2Cardiovascular Infections
05/2020 - 09/2013
2Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2020 - 01/2018
2Hepatitis
01/2020 - 01/2018
2Cholecystitis
01/2020 - 01/2018
2HIV Infections (HIV Infection)
01/2020 - 01/2016
2Meningitis
01/2020 - 01/2018
2Arthritis (Polyarthritis)
08/2014 - 05/2008
1Taste Disorders (Taste Disorder)
01/2022
1Body Weight (Weight, Body)
10/2021
1Hepatomegaly
01/2021
1Protein-Energy Malnutrition (Marasmus)
01/2021
1Aneurysm (Aneurysms)
05/2020
1Fistula
05/2020
1Abscess
05/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Venous Thrombosis (Deep-Vein Thrombosis)
05/2019
1Tuberculosis (Tuberculoses)
05/2019
1Bacterial Infections (Bacterial Infection)
09/2018
1Lung Neoplasms (Lung Cancer)
01/2018
1Mediastinitis
12/2017
1Heart Valve Diseases (Valvular Heart Disease)
07/2017
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
07/2017
1Fever (Fevers)
07/2017

Drug/Important Bio-Agent (IBA)

18Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2022 - 08/2010
13Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 02/2013
11Azithromycin (Zithromax)FDA LinkGeneric
01/2022 - 03/2020
10Immunoglobulin G (IgG)IBA
11/2019 - 08/2010
7Doxycycline (Periostat)FDA LinkGeneric
10/2021 - 08/2010
7Anticardiolipin AntibodiesIBA
01/2020 - 07/2013
6AntibodiesIBA
10/2019 - 07/2013
4AntioxidantsIBA
01/2021 - 01/2016
3Immunoglobulin M (IgM)IBA
10/2019 - 08/2010
2TroponinIBA
12/2021 - 07/2020
2Tetracycline (Achromycin)FDA LinkGeneric
10/2021 - 08/2021
2C-Reactive ProteinIBA
08/2021 - 07/2020
2Pharmaceutical PreparationsIBA
01/2021 - 04/2013
2AntigensIBA
01/2021 - 10/2019
2VitaminsIBA
01/2021 - 05/2017
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2020 - 07/2020
2ZincIBA
12/2020 - 07/2020
2Biological ProductsIBA
01/2020 - 01/2019
2Phospholipids (Phosphatides)FDA LinkGeneric
11/2019 - 03/2016
2Oxygen (Dioxygen)IBA
01/2017 - 01/2016
2Amoxicillin (Wymox)FDA LinkGeneric
01/2017 - 01/2017
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022
1N-(2-cyanoethylene)urea (BA 1)IBA
01/2022
1fibrin fragment D (D-dimer)IBA
12/2021
1Nucleic AcidsIBA
09/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2021
1Methionine (L-Methionine)FDA Link
01/2021
1angiotensin I (1-7)IBA
01/2021
1Angiotensin IIBA
01/2021
1Angiotensin IIIBA
01/2021
1Glutathione (Reduced Glutathione)IBA
01/2021
1IronIBA
01/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1VaccinesIBA
01/2021
1Troponin CIBA
12/2020
1Proteins (Proteins, Gene)FDA Link
12/2020
1Biological FactorsIBA
07/2020
1CreatinineIBA
07/2020
1LactoseFDA LinkGeneric
01/2020
1Isoantigens (Alloantigen)IBA
01/2020
1Chloroquine (Aralen)FDA LinkGeneric
01/2020
1Butyrates (Butyrate)IBA
01/2020
1Ethanolamine (Colamine)IBA
05/2019
1AnticoagulantsIBA
05/2019
1Penicillins (Penicillin)FDA Link
01/2019
116S Ribosomal RNAIBA
09/2018
1chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
01/2018
1EnzymesIBA
07/2017
1Antiphospholipid AntibodiesIBA
07/2017
1ImmunosorbentsIBA
07/2017

Therapy/Procedure

5Therapeutics
01/2021 - 11/2014
4Antibiotic Prophylaxis
01/2016 - 07/2013
2Prostheses and Implants (Prosthesis)
05/2020 - 11/2014
2Fecal Microbiota Transplantation
10/2018 - 08/2017
1Drug Therapy (Chemotherapy)
01/2021
1Blood Vessel Prosthesis
05/2020
1Length of Stay
03/2020
1Catheters
08/2017